News | 2021.07.19
The Agence française de développement (AFD) and ANRS | Maladies infectieuses émergentes, in partnership with the Institut Pasteur, IRD, and laboratories across 13 African countries, are launching the joint AFROSCREEN project. This project meets an urgent need for surveillance of the development of SARS-CoV-2 variants and other emerging pathogens by bolstering laboratory genomic sequencing...
Document de presse | 2021.07.16
Over the past six months, the World Health Organization has categorized four SARS-CoV-2 variants as being "of concern" because they are more transmissible or may escape the immune response. They have been termed the Alpha, Beta, Gamma and Delta variants. Scientists from the Institut Pasteur, in collaboration with the French National Health Insurance Fund (CNAM), Ipsos and Santé publique France,...
News | 2021.07.27
The National Library of France (BnF) awarded the two Prix Pasteur Vallery-Radot 2021 to Jérôme Gros and Etienne Patin, researchers at the Institut Pasteur. Here are the presentation of the two laureates. This year, the two Pasteur Vallery-Radot Prizes went to:Jérôme Gros, Research Director at the Institut Pasteur and Head of the Dynamic Regulation of Morphogenesis Unit, for his research...
Document de presse | 2021.07.21
COVID-19 is a viral disease with respiratory symptoms that can induce fatal pneumonia. Understanding how SARS-CoV-2 spreads in the respiratory tract can help scientists identify the parameters controlling the severity of infection. Scientists from the Institut Pasteur, the CNRS and Inserm found that SARS-CoV-2 multiplies efficiently in the respiratory tract, and that it primarily targets ciliated...
News | 2021.07.27
On July 22, 2021, the Institut Pasteur and Université de Paris signed an association agreement. The agreement was signed in the Salle des Actes at the Institut Pasteur, a place that is steeped in history. The two institutions have a shared scientific ambition to contribute to progress in human health.Signing of the association agreement in the Salle des Actes. Credit: Institut Pasteur/Thomas Lang...
Document de presse | 2021.07.12
Since the start of the COVID-19 pandemic, various therapeutic approaches have been explored to tackle the disease. Scientists from the Institut Pasteur have shown that ivermectin, a drug used commercially as an antiparasitic treatment, offers protection from COVID-19 symptoms in an animal model. The scientists observed that taking ivermectin was associated with reduced inflammation in the...
Page avancée | 2021.08.09
The Institut Pasteur has been acting in favor of Open Science by adopting two founding texts in May 2021: a Charter for Open Access to publications and a Policy for the management and sharing of research data and software code.
News | 2021.08.13
In 2020 when many countries around the world struggled with a large burden of COVID-19 cases, the Lao PDR stood out as a country with low reported numbers of SARS-CoV-2 infections. Was it due to a low circulation of the virus or to an inadequate surveillance system? To answer this question, a seroprevalence study has been conducted by Institut Pasteur du Laos, in collaboration with Institut...
Article | 2021.08.18
Thank your for your interest.You are now signed up for the Institut Pasteur newsletter.You will receive it once a month.You can easily unsubscribe at any moment by using the unsubscribe link that appears in each email.If you do not receive this email, please check your spam, bulk email folder or promotions tab in gmail.Institut Pasteur
Article | 2021.08.18
Thank you for signing up for the Institut Pasteur newsletter.You will soon receive an email asking you to confirm this subscription.If you don’t receive this email, we suggest you check in your spam folder.Institut Pasteur